RICERCA
AUTORI
RIVISTE
Sfoglia per RIVISTA
HAEMATOLOGICA
Collezione AO Cuneo
Items : 34
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study. in Haematologica / Haematologica. 2023 Aug 1;108(8):2091-2100. doi: 10.3324/haematol.2022.282116.
2023
AO Alessandria
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano
ASL Cuneo 1
AOU Novara
Starza ID; Cuneo A; Foà R; Vignetti M; Piciocchi A; Guarini A; Del Giudice I; Fazi P; Albano F; Neri A; De Novi LA; De Propris MS; Nanni M; Molinari MC; Visentin A; Vitale C; Mattiello V; Pietrasanta D; Liberati AM; Giordano A; Deodato M; Galieni P; Patrizi VB; Gottardi D; Tani M; Arcari A; Musuraca G; Levato L; Marchetti M; et alii...
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study. in Haematologica / Haematologica. 2022 Jun 1;107(6):1470-1473. doi: 10.3324/haematol.2021.280325.
2022
AO Cuneo
ASL Cuneo 1
AOU Città della Salute di Torino
AOU Novara
Cuneo A; Laurenti L; Ghia P; Foà R; Trentin L; Pompili M; Tedeschi A; Mauro FR; Del Poeta G; Scarfò L; Autore F; Tomasso A; Di Sevo D; Arena V; Deodato M; Ielo C; Frustaci AM; Piciocchi A; Rughini A; Cassin R; Albano F; Quaglia FM; Pennese E; Moia R; Gentile M; Murru R; Motta M; Coscia M; Visentin A; et alii...
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study. in Haematologica / Haematologica. 2022 Apr 1;107(4):996-999. doi: 10.3324/haematol.2021.279851.
2022
AO Cuneo
AOU Città della Salute di Torino
Foà R; Ferrara F; Chiaretti S; Defina M; Pizzolo G; Castella B; Rizzari C; Del Principe MI; Giglio F; Giaccone L; Fracchiolla NS; Chiusolo P; Zappasodi P; La Starza R; Favre C; Tanasi I; Gurrieri C; Cerrano M; Forghieri F; Malagola M; Dargenio M; Scattolin AM; Papayannidis C; Curti A; Olivi M; Bonifacio M;
The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation. in Haematologica / Haematologica. 2022 Apr 1;107(4):868-876. doi: 10.3324/haematol.2021.278304.
2022
AO Cuneo
Visentin A; Bonaldi L; Rigolin GM; Mauro FR; Martines A; Frezzato F; Pravato S; Gargarella LR; Bardi MA; Cavallari M; Volta E; Cavazzini F; Nanni M; Facco M; Piazza F; Guarini A; Foà R; Semenzato G; Cuneo A; Trentin L;
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06. in Haematologica / Haematologica. 2021 Oct 1;106(10):2578-2587. doi: 10.3324/haematol.2020.252825.
2021
AO Alessandria
AO Cuneo
AOU Città della Salute di Torino
Bassan R; Cortelezzi A; Falini B; Pavoni C; Todisco E; Bernardi M; Corradini P; Ciceri F; Campiotti L; Mattei D; Cavattoni I; Scattolin AM; Tajana M; Borlenghi E; Cattaneo C; De Paoli L; Terruzzi E; Gianfaldoni G; Mannelli F; Ferrero D; Audisio E; Grassi A; Intermesoli T; Oldani E; Zanghi' P; Michelato A; Delaini F; Elidi L; Cavagna R; et alii...
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913. in Haematologica / Haematologica. 2021 Jun 1;106(6):1559-1568. doi: 10.3324/haematol.2020.247973.
2021
AOU Città della Salute di Torino
AO Cuneo
Vitale A; Cattaneo C; Mattei D; Fracchiolla N; Cerrano M; Cairoli R; Candoni A; Papayannidis C; De Fabritiis P; Di Raimondo F; Capria S; Apicella V; Spinelli O; Santoro A; Pierini V; Puzzolo MC; Lauretti A; Canichella M; La Starza R; Albertini Petroni G; Elia L; Ansuinelli M; Taherinasab A; Cavalli M; Cafforio L; Piciocchi A; Della Starza I; Messina M; Chiaretti S; et alii...
High rate of MRD-responses in young and fit patients with IGHV mutated chronic lymphocytic leukemia treated with front-line fludarabine, cyclophosphamide, and intensified dose of ofatumumab (FCO2). in Haematologica / Haematologica. 2020 Nov 1;105(11):2671-2674. doi: 10.3324/haematol.2019.235705.
2020
AOU Città della Salute di Torino
AO Cuneo
AO Alessandria
Foà R; Guarini AR; Raponi S; De Propris MS; Della Starza I; Del Giudice I; Albano F; Cuneo A; Neri A; Piciocchi A; Vignetti M; Nanni M; Musolino C; Battistini R; Del Poeta G; Pietrasanta D; Gozzetti A; Liberati AM; Reda G; Tedeschi A; Re F; Soddu S; Mauro FR; Angelucci E; Zaja F; Coscia M; Ilariucci F; Molica S;
Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial. in Haematologica / Haematologica. 2020 Jul;105(7):1937-1947. doi: 10.3324/haematol.2019.226407. Epub 2019 Oct 3.
2020
ASL Torino 4
AOU Città della Salute di Torino
AO Cuneo
Boccadoro M; Larocca A; Hájek R; Falco P; Palumbo A; Cellini C; Marasca R; Gentile M; Baldini L; Tosi P; Petrucci MT; Santoro A; Poggiu M; Aquino S; Gazzera G; De Rosa L; Pavone V; Pescosta N; Pezzatti S; Grasso M; Rota-Scalabrini D; Spada S; Paris L; Ballanti S; Bringhen S; D'Agostino M;
HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Apr;105(4):1042-1054. doi: 10.3324/haematol.2019.217430. Epub 2019 Jul 9.
2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara
Coscia M; Boccadoro M; Gattei V; Gaidano G; Foà R; Massaia M; Zenz T; Bernardi R; Mauro FR; Laurenti L; Del Poeta G; Kodipad AA; Omedè P; Bonello L; Marchetti M; Magliulo D; Rossi D; Pozzato G; Bo MD; Bomben R; Kopecka J; Salvetti C; Riganti C; Todaro M; Vitale C; Griggio V;
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial. in Haematologica / Haematologica. 2019 Nov;104(11):2241-2248. doi: 10.3324/haematol.2018.209932. Epub 2019 Apr 11.
2019
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino
AO Alessandria
Tarella C; Ladetto M; Corradini P; Passera R; Gianni AM; Rambaldi A; Billio A; Gueli A; Mantoan B; Angrilli F; Perrone T; Semenzato G; Lanza F; Parvis G; Dondi A; Narni F; Zallio F; Zoli V; Devizzi L; Tucci A; Rota-Scalabrini D; Di Raimondo F; Stelitano C; Ciceri F; Rossini F; Castellino C; Gini G; Liberati AM; Musso M; et alii...
Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study. in Haematologica / Haematologica. 2019 Jan;104(1):e4-e8. doi: 10.3324/haematol.2017.183590. Epub 2018 Aug 3.
2019
ASL Torino 5
ASL Torino 4
AO Ordine Mauriziano
AO Cuneo
AOU Città della Salute di Torino
Levis A; Saglio G; Musto P; Bonferroni M; Finelli C; Tassara R; Ferrero D; Cametti G; Poloni A; Balleari E; Sanna A; Allione B; Danise P; Salvi F; Ceccarelli M; Castiglione A; Masiera E; Gioia D; Messa E; Santini V;
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice. in Haematologica / Haematologica. 2019 Aug;104(8):1589-1596. doi: 10.3324/haematol.2018.205054. Epub 2019 Feb 28.
2019
AO Cuneo
AOU Città della Salute di Torino
ASL Città di Torino
AO Alessandria
Baccarani M; Saglio G; Pane F; Ferrero D; Lunghi F; Specchia G; Iuliano F; Sorà F; Caocci G; Russo S; Musto P; Luciano L; Giai V; Sgherza N; Cavazzini F; Levato L; Stagno F; Annunziata M; Santoro M; Breccia M; Cedrone M; Latagliata R; Cattaneo D; Iurlo A; Bocchia M; Rapezzi D; Galimberti S; Crugnola M; Capodanno I; et alii...
2019
AO Cuneo
Zamagni E; Nanni C; Dozza L; Carlier T; Tacchetti P; Versari A; Chauvie S; Gallamini A; Attal M; Gamberi B; Caillot D; Patriarca F; MacRo M; Boccadoro M; Garderet L; Fanti S; Perrot A; Gay F; Sonneveld P; Karlin L; Bodet-Milin C; Moreau P; Kraeber-Bodéré F; Cavo M;
Diagnosis of maternal Hodgkin lymphoma following abnormal findings at non invasive prenatal screening test (NIPT): Report of two cases in Haematologica
2019
AO Cuneo
Elba S; Castellino A; Soriasio R; Castellino C; Bonferroni M; Grasso M; Mattei D; Mordini N; Foglietta M; Mastruzo B; Priotto R; Zonta A; Rapezzi D; Massaia M;
IgM multiple myeloma and waldenstrom macroglobulinemia: Diagnostic challenges and therapeutic options. A report of two cases in Haematologica
2019
AO Cuneo
Elba S; Castellino A; Bonferroni M; Castellino C; Mattei D; Mordini N; Foglietta M; Priotto R; Rapezzi D; Sorasio R; Grasso M; Massaia M;
Phase I study of the heparanase inhibitor roneparstat: an innovative approach for ultiple myeloma therapy. in Haematologica / Haematologica. 2018 Oct;103(10):e469-e472. doi: 10.3324/haematol.2017.182865. Epub 2018 Apr 26.
2018
AO Cuneo
Nagler A; Sanderson RD; Rambaldi A; Pace S; Paoletti D; Barbieri P; Celeghini I; Einsele H; Magen H; Specchia G; Grasso M; Galli M; Chatterjee M;
Multifaceted immune checkpoint expression and senescent markers impairs bone marrow V?9V?2 T-cell function in multiple myeloma patients in Haematologica
2018
AO Cuneo
Castella B; Riganti C; Foglietta M; Tripoli E; Giannotta C; Massaia M;
ABCA1: an unexpected role in V?9V?2 T-cell activation by dendritic cells in Haematologica
2018
AO Cuneo
Massaia M; Riganti C; Foglietta M; Tripoli E; Castella B;
2018
AO Cuneo
AO Alessandria
Spinelli O; Salmoiraghi S; Zanghi P; Cavagna R; Michelato A; Buklijas K; Zannino L; Intermesoli T; Lussana F; Delaini F; Oldani E; Caprioli C; Stefanoni P; Gianfaldoni G; Marmont F; Ferrero D; Terruzzi E; De Paoli L; Rossi G; Borlenghi E; Cavattoni I; Tajana M; Scattolin AM; Mattei D; Corradini P; Campiotti L; Ciceri F; Bernardi M; Todisco E; et alii...
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification. in Haematologica / Haematologica. 2017 Sep;102(9):e352-e355. doi: 10.3324/haematol.2016.156901. Epub 2017 Jun 8.
2017
AO Ordine Mauriziano
AOU Città della Salute di Torino
AO Cuneo
Piciocchi A; Boncompagni R; Orlando S; Cuneo A; Galieni P; Marasca R; Vannata B; Pozzato G; Efremov DG; Molica S; Coscia M; Massaia M; D'Arena G; Del Poeta G; Mannina D; Mauro FR; Ciolli S; Autore F; Innocenti I; Laurenti L; Vincelli D; Liberati AM; Russo F; Foá R;
Steroid treatment of acute graft-versus-host disease grade I: a randomized trial. in Haematologica / Haematologica. 2017 Dec;102(12):2125-2133. doi: 10.3324/haematol.2017.171157. Epub 2017 Sep 29.
2017
AO Cuneo
AOU Città della Salute di Torino
Bonifazi F; Raiola AM; Gualandi F; Risitano A; Sormani MP; Signori A; Selleri C; Van Lint MT; Massi D; Mammoliti S; Sorasio R; Sica S; Santarone S; Chiusolo P; Berger M; Fagioli F; Severino A; Cupri A; Bacigalupo A; Milone G;
Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study. in Haematologica / Haematologica. 2016 Apr;101(4):e139-41. doi: 10.3324/haematol.2015.138388. Epub 2015 Dec 24.
2016
AO Cuneo
Salati M; Capodanno I; Chauvie S; Gandolfi L; Pesce EA; Merli F; Pellegrini C; Luminari S; Federico M; Argnani L; Zinzani PL;
2016
AO Alessandria
AO Ordine Mauriziano
AO Cuneo
Bassan R; Intermesoli T; Masciulli A; Boschini C; Gianfaldoni G; Marmont F; Cavattoni I; Mattei D; Terruzzi E; De Paoli L; Rossi G; Borlenghi E; Ciceri F; Bernardi M; Scattolin AM; Todisco E; Campiotti L; Corradini P; Cortelezzi A; Tajana M; Ferrero D; Cignetti A; Marfisi RM; Delaini F; Zanghì P; Oldani E; Spinelli O; Audisio E; Cortelazzo S; et alii...
Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia. in Haematologica / Haematologica. 2015 Jun;100(6):786-93. doi: 10.3324/haematol.2014.123273. Epub 2015 Mar 6.
2015
AO Cuneo
AOU Città della Salute di Torino
Rambaldi A; Marfisi RM; Oldani E; Gallamini A; Cortelazzo S; Fumagalli M; Marmont F; Borlenghi E; Parolini M; Tosi M; Spinelli O; Scattolin AM; Corti C; Cortelezzi A; Romani C; Mattei D; Cassibba V; Rossi G; Pogliani EM; Audisio E; Intermesoli T; Masciulli A; Bassan R;
Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: a multicenter retrospective cohort study. in Haematologica / Haematologica. 2015 Aug;100(8):e295-8. doi: 10.3324/haematol.2015.127183. Epub 2015 Apr 17.
2015
AO Cuneo
Mumoli N; Ageno W; Dentali F; Borretta V; Bonfanti C; Sabatini S; Lupoli R; Bellesini M; Pomero F; Franchini M; Riva N; Di Minno MN;
Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. in Haematologica / Haematologica. 2014 Sep;99(9):e159-61. doi: 10.3324/haematol.2014.106740. Epub 2014 Jun 27.
2014
AO Cuneo
Massaia M; Morra E; Nichelatti M; De Paoli L; Rossi D; Frustaci AM; Gallamini A; Motta M; Ghia P; Cascavilla N; Orlandi E; Petrizzi VB; Coscia M; Gaidano G; Tedeschi A; Montillo M;
Imatinib and ruxolitinib association: first experience in two patients. in Haematologica / Haematologica. 2014 Jun;99(6):e76-7. doi: 10.3324/haematol.2013.102525. Epub 2014 Mar 14.
2014
AO Cuneo
Cortelezzi A; Binda F; Santambrogio E; Bucelli C; Fermo E; Cattaneo D; Rapezzi D; Gianelli U; Iurlo A;
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale. in Haematologica / Haematologica. 2014 Jun;99(6):1107-13. doi: 10.3324/haematol.2013.103218. Epub 2014 Mar 21.
2014
AO Cuneo
Gallamini A; Barrington SF; Hutchings M; Luminari S; Salvi F; Viviani S; Bolis S; Rusconi C; Brice P; Dann EJ; Trentin L; Casasnovas O; Pulsoni A; Coleman M; Hofman MS; Rigacci L; Seymour JF; Zaucha JM; Loft A; Mikhaeel GN; Biggi A; Meignan M; Kostakoglu L; Gregianin M; Chauvie S;
Myelofibrosis and following chronic myeloid leukemia: Imatinib and ruxolitinib treatment in two cases in Haematologica
2013
AO Cuneo
Iurlo A; Rapezzi D; Binda F; Cattaneo D; Zaninoni A; Fattizzo B; Gianelli U; Cortelezzi A;
Upstaging by pet-ascertained bone and bone marrow involvement in hodgkin lymphoma-definitions matter in Haematologica
2013
AO Cuneo
Borra A; El-Galaly TC; Zaucha JM; Rigacci L; Rapezzi D; Rago A; Bolis S; Gavarotti P; Rusconi C; Trentin L; Stelitano C; Biggi A; Gormsen LC; D'Amore F; Hutchings M; Gallamini A;
RWPSS validation in an independent cohort of 946 myelodysplastic syndrome patients from the MDS piedmont registry in Haematologica
2012
ASL Asti
ASL Torino 4
ASL Torino 5
AO Cuneo
Messa E; Gioia D; Salvi F; Allione B; Audisio E; Ferrero D; Crisà E; Lunghi M; Freilone R; Falco P; Cametti G; Bonferroni M; Ciravegna G; Cilloni D; Saglio G; Levis A;
Blastic plasmacytoid dendritic cell leukemia: Preliminary results of a retrospective italian multicentric study in Haematologica
2011
AO Cuneo
Pagano L; Valentini C; Di Paolantonio G; Melillo L; Gaidano G; Venditti A; Specchia G; Cattaneo C; Pica G; Spadea A; D'Arco A; Candoni A; Rodeghiero F; Abbadessa A; Piccin A; Ballerini F; Sorasio R; Nosari A; Caramatti C; Invernizzi R; Aversa F; Pacilli L; Musto P; Peli A; Quintini G; Forghieri F; Facchetti F; Pavan L; Leone G; et alii...
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. in Haematologica / Haematologica. 2006 Apr;91(4):475-81.
2006
AO Cuneo
Levis A; Torchio P; Gregianin M; Pelosi E; Versari A; Castagnoli A; Biggi A; Tavera S; Stelitano C; Trentin L; Iannitto E; Sancetta R; Vitolo U; Luminari S; Capodanno I; Bosi A; Nassi L; Merli F; Gallamini A; Rigacci L;
The epidemiology of fungal infections in patients with hematologic malignancies: The SEIFEM-2004 study in Haematologica
2006
AO Cuneo
Pagano L; Caira M; Candoni A; Offidani M; Fianchi L; Martino B; Pastore D; Picardi M; Bonini A; Chierichini A; Fanci R; Caramatti C; Invernizzi R; Mattei D; Mitra ME; Melillo L; Aversa F; Van Lint MT; Falcucci P; Valentini CG; Girmenia C; Nosari A;